SEC Filings
Bitmine Keeps Buying Ethereum — But Its Treasury Value Falls To $14.3 Billion
The company holds 4.97% of Ethereum's supply and projects $309 million in annual staking rewards from tokens already deployed.
SEC Filings
The company holds 4.97% of Ethereum's supply and projects $309 million in annual staking rewards from tokens already deployed.
SEC Filings
The small study uses historical comparisons, while hospital and patient surveys test a path to adoption before broad insurance coverage.
SEC Filings
The financing also funded approximately $100 million in share buybacks and $112.8 million in contracts to limit conversion costs.
SEC Filings
The incoming CEO's bonus target is 120% of salary, and CFO Paul Joachimczyk received a $1.5 million retention stock award.
SEC Filings
The purchases added 479,725 ordinary shares to treasury, bringing the total to approximately 1.9% of issued capital.
SEC Filings
The board had selected Abbate in October; Chairman John Mendel says the earlier handoff gives him more time with teams and customers.
SEC Filings
CNH plans to pay down debt with the proceeds while retaining 30% of the construction venture and its equipment-financing business.
SEC Filings
The liver-cancer treatment company raised its 2026 sales outlook to $115 million–$117 million while spending more on trials and expansion.
SEC Filings
ZYNLONTA sales rose to $21 million from $15.8 million, while lower research costs helped reduce operating expenses by 24%.
SEC Filings
Management expects $45 million–$60 million in annual savings by year-end 2027 as it adds four drugs to its hospital sales platform.
SEC Filings
The experimental cancer-drug developer expects its $442.3 million in cash and investments to cover operations into the first half of 2029.
SEC Filings
Common-share sales funded both the Stretch repurchases and $81.9 million in bitcoin purchases, while the company also paid preferred dividends.